betaxolol has been researched along with chitosan in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Dhyanandhan, G; Jain, K; Kumar, RS; Sood, S | 1 |
| Chen, Y; Gui, R; Hou, D; Li, J; Ping, Q; Tao, Q; Tian, S; Yang, F; Zang, L; Zhao, Y | 1 |
2 other study(ies) available for betaxolol and chitosan
| Article | Year |
|---|---|
Betaxolol hydrochloride loaded chitosan nanoparticles for ocular delivery and their anti-glaucoma efficacy.
Topics: Administration, Ophthalmic; Animals; Antihypertensive Agents; Betaxolol; Chickens; Chitosan; Chorioallantoic Membrane; Drug Carriers; Drug Stability; Glaucoma; Intraocular Pressure; Male; Nanoparticles; Rabbits; Tears; Treatment Outcome | 2013 |
Montmorillonite/chitosan nanoparticles as a novel controlled-release topical ophthalmic delivery system for the treatment of glaucoma.
Topics: Administration, Topical; Animals; Aqueous Humor; Bentonite; Betaxolol; Cell Survival; Chitosan; Cornea; Delayed-Action Preparations; Dialysis; Drug Carriers; Drug Delivery Systems; Drug Liberation; Epithelial Cells; Glaucoma; Humans; Intraocular Pressure; Nanoparticles; Ophthalmic Solutions; Particle Size; Rabbits; Static Electricity | 2018 |